Estrus 1.0 mg Solution is a Health Canada–registered veterinary drug (DIN 02299283) held by Rafter 8 Products Inc, containing Estradiol Cypionate. Health Canada lists its status as Cancelled Post Market (status date 30 Jul 2024). Nexara Health has matched 12 registrations of Estradiol Cypionate across 1 other regulated market.
Health Canada registration
| DIN | 02299283 |
|---|---|
| Brand name | Estrus |
| Active ingredient | Estradiol Cypionate |
| Strength | 1.0 mg |
| Dosage form | Solution |
| Route | Intramuscular |
| Company | Rafter 8 Products Inc |
| Status | Cancelled Post Market — 30 Jul 2024 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Estradiol Cypionate registered in other markets
12 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Depo-Estradiol | Pharmacia & Upjohn Company LLC | Injection | listed | FDA NDC | |
| United States | estradiol cypionate | zhejiang xianju pharmaceutical co., Ltd. | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | Fagron Inc | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | Valdepharm | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | Steroid S.p.A. | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | AX Pharmaceutical Corp | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | Darmerica, LLC | Powder | FDA NDC | ||
| United States | Estradiol Cypionate | Shakti Lifescience Private Limited | Powder | FDA NDC |
See every manufacturer of Estradiol Cypionate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Estrus (DIN 02299283) marketed in Canada?
No. Health Canada lists DIN 02299283 as Cancelled Post Market as of 30 Jul 2024.
Who holds the Canadian licence for this product?
Rafter 8 Products Inc is the company of record in the Health Canada Drug Product Database.
Is Estradiol Cypionate registered outside Canada?
Yes — Nexara Health has matched 12 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02299283, status date 2024-07-30; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02299283, status date 2024-07-30; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02299283, status date 2024-07-30; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.